HomeSUVEN • NSE
add
Suven Life Sciences Ltd
Previous close
₹163.53
Day range
₹158.05 - ₹165.73
Year range
₹102.50 - ₹299.99
Market cap
36.80B INR
Avg Volume
424.11K
P/E ratio
-
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 28.09M | 74.46% |
Operating expense | 1.08B | 153.85% |
Net income | -1.02B | -160.56% |
Net profit margin | -3.63K | -49.35% |
Earnings per share | — | — |
EBITDA | -1.03B | -163.10% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.57B | 54.67% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 2.81B | — |
Shares outstanding | 224.00M | — |
Price to book | 12.92 | — |
Return on assets | — | — |
Return on capital | -93.06% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -1.02B | -160.56% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1989
Website
Employees
138
